Bacterial interference

Critical Reviews in Microbiology

Volumn 25, Issue 3, 1999, Pages 155-172

  Brook, Itzhak ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha hemolytic streptococcus; Antagonism; Bacterial interference; Bacteriocins; Lactobacillus

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BACTERIOCIN; CEFPROZIL; PENICILLIN G; STREPTOMYCIN SULFATE;

BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM; CELL INTERACTION; GASTROINTESTINAL INFECTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; NONHUMAN; OTITIS MEDIA; PHARYNGITIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; TONSILLITIS; UROGENITAL TRACT INFECTION;

ANTIBIOSIS; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PHYSIOLOGY; BACTERIOCINS; HUMANS;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; NEGIBACTERIA; POSIBACTERIA; STREPTOCOCCUS;

EID: 0032819845     PISSN: 1040841X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408419991299211     Document Type: Review

References (117)

1. 1. Wannamaker, L. W. 1980. Bacterial interference and competition, Scand. J. Infect. Dis. Suppl. Suppl 24: 82-85.
2. 2. Smith, H. 1995. The revival of interest in mechanisms of bacterial pathogenicity, Biol. Rev. 70: 277-316.
3. 3. Pasteur, L. and Joubert, J. F. 1877. Charbon et septicémie, C.R. Soc. Biol. Paris 85: 101-115.
4. 4. Cantani, A. 1885. Un tentativo di batterioterapia, G. Int. Sci. Med. 7: 493-498.
5. 5. Emmerich, R. 1887. Die theilung des milzbrandes, Arch. Hyg. (Berlin) 6: 442-501.
6. 6. Florey, H. W., Chain, E., Heatley, N. G., Jennings, M. A., Sanders, A. G., Abraham, E. P., and Florey, M. E. 1949. Antibiotics, Oxford University Press, London, 417-565.
7. 7. Nissle, A. 1916. Ueber die Grundlagen einer neuen aursachlichen Bekämpfung de patho-ligischen Darmflora, Dtsch. Med. Wochenschr. 42: 1181-1184.
8. 8. Gratia, A. 1925. Sur un remarquable exemple d'antagonisme entre deux souches de colibacille, C.R. Seances Soc. Biol. Fil. 93: 1040-1041.
9. 9. Metchnikoff, E. 1894. Recherches sur le cholera et les vibrions. IV. Sur l'immunité et la receptivité vis-à-vis du cholera intestinal, Ann. Inst. Pasteur (Paris) 8: 529-589.
10. 10. Newman, D. 1915. The treatment of cystitis by intravesical injections of lactic bacillus cultures, Lancet ii: 330.
11. 11. Shinefield, H. R., Aly, R., Maibach, H., Ribble, J. C., Boris, M., and Eichenwald, H. F. Factors influencing colonization of mucous membranes and skin surfaces with Staphylococcus aureus, in Microbiology - 1995. D., Schlessinger, Ed., American Society for Microbiology, 1975, 110-115.
12. 12. Martin, R. R. and White, A. 1968. The reacquisition of staphylococci by treated carriers: A demonstration of bacterial interference, J. Lab. Clin. Med. 71: 791-797.
13. 13. Sprunt, K., Leidy, G. A., and Redman, W. 1971. Prevention of bacterial overgrowth, J. Infect. Dis. 123: 1-10.
14. 14. Iba, A. M., Berchieri, Junior, A., and Barrow, P. A. 1995. Interference between Salmonella serotypes in intestinal colonisation of chickens: correlation with in vitro behavior. FEMS Microbiol. Le 1: 131; 153-159.
15. 15. Barc, M. C., Bourlioux, P., Boureau, H., Nerbone, F., and Wasconcellos da Costa, E. 1986. Bacterial interference with skin colonization in germfree hairless mice, Can. J. Microbiol. Sept. 32: 751-755.
16. 16. Reever, P. 1965. The bacteriocins, Bacteriol. Rev. 29: 24-45.
17. 17. Gratia, J. P. and Grenier, L. 1992. Differential activity of bacteriocins and cefotaxime against Serratia marcescens clinical isolates SMG40 and its pigmented variant, Int. J. Microbiol. Virol. Parasitol. Infect. Dis. 276: 340-346.
18. 18. Laukova, A. and Marekova, M. 1993. Antibacterial spectrum of bacteriocin-like substances produced by rumen staphylococci, Folia Microbiol. Praha. 38: 74-76.
19. 19. Fredericq, P. 1957. Colicins, Ann. Rev. Microbiol. 11: 7-22.
20. 20. Bradley, D. 1967. Ultrastructure of bacteriophage and bacteriocins, Bacteriol. Rev. 31: 230-314.
21. 21. Bradley, D. E. 1966. The structure of pyocin particles released from Pseudomonas aeruginosa by mitomycin C, Int. Congr. Elect. Microsc. 6: 115-116.
22. 22. Parker, M. W., Pattus, F., Tucker, A. D., and Tsernoglou, D. 1989. Structure of the membrane pore forming fragment of the colicin A, Nature 337: 93-96.
23. 23. Clawson, C. C. and Dajani, A. S. 1970. Effect of bactericidal substance from Staphylococcus aureus on group A streptococci II. Structural alterations, Infect. Immun. 1: 491-498.
24. 24. Ellison, J. S., Mattern, C. F. T., and Daniel, W. A. 1971. Structural changes in Clostridium botulinum type E after treatment with boticin S51, J. Bacteriol. 108: 526-534.
25. 25. Tagg, J. R., Dajani, A. S., and Wannamaker, L. W. 1976. Bacteriocins of Gram-positive bacteria. Bacteriol. Rev. 40: 722-756.
26. 26. Govan, J. R. W. 1974. Studies on the pyocins of Pseudomonas aeruginosa: morphology and mode of action of contractile pyocins. J. Gen. Microbiol. 80: 1-15.
27. 27. Govan, J. R. W. 1974. Studies on the pyocins of Pseudomonas aeruginosa: production of contractiles and flexuous pyocins of Pseudomonas aeruginosa, J. Gen. Micriobiol. 80: 15-30.
28. 28. Daw, M. A. and Falkiner, F. R. 1993. The ultrastructure of cloacin C5 of Enterobacter cloacae, Proc. R. Microscop. Soc. 28 (Suppl. 1), 24.
29. 29. Braun, V., Pilsi, H., and Gross, P. 1994. Colicins, structure, mode of action, transfer through membranes and evolution, Arch. Microbiol. 161: 199-206.
30. 30. Sano, Y., Matsui, H., Kobayashi, M., and Kageyama, M., 1990. Pyocins S1 and S2, bacteriocins of Pseudomonas aeruginosa, in Pseudomonas, Biotransformation, Pathogensis, Silver, S., Chakrabarty, A. M., Iglewski, B., and Kalpans, E., Eds. American Society of Microbiology, Washington, D.C., 352-358.
31. 31. Nes, I. F., Diep, D. B., Havarstein, L. S., Brurberg, M. B., Vincent, E., and Helge H. 1996. Biosynthesis of bacteriocins in lactic acid bacteria. Antonie van Leuwenhoek 70: 113-128.
32. 32. Stiles, M. E. 1994. Bacteriocins produced by Leuconostocs species, J. Dairy Sci. 77: 2718-2722.
33. 33. Tagg, J. R. 1984. Production of bacteriocin-like inhibitors by group A streptococci of nephritogenic M types, J. Clin. Microbiol. 19: 884-887.
34. 34. Tzannetis, S. E., Bigis, A., Konidaris, N., Ioannidis, H., Genimatas, V., and Papavassiliou, J. 1991. In vitro bacteriocin-mediated antagonism by oral streptococci against human carrier strains of staphylococci, J. Appl. Bac. 70: 294-301.
35. 35. Fabio U., Bondi M., Manicardi G., Messi P., Neglia R. 1987. Production of bacteriocin-like substances by human oral streptococci, Micron 10: 363-370.
36. 36. Chikindas, M. L., Novak, J., Driessen, A. J., Konings, W. N., Schilling, K. M., and Caufield, P. W. 1995. Mutacin II, a bactericidal antibiotic from Streptococcus mutans, Antimicrob. Agents Che. 39: 2656-2660.
37. 37. Tompkins, G. R., Peavey, M. A., Birchmeier, K. R., and Tagg, J. R. 1997. Bacteriocin production and sensitivity among co-aggregating and non-co-aggregating oral streptococci, Oral Microbiol. I. 12: 98-105.
38. 38. Galvez, A., Valdivia, E., Maqueda, M., and Montoya, E. 1985. Production of bacteriocin-like substances by group D streptococci of human origin. Micron. 43: 223-232.
39. 39. Jett, B. D. and Gilmore, M. S. 1990. The growth-inhibitory effect of the Enterococcus faecalis bacteriocin encoded by pAD1 extends to the oral streptococci. J. Dent. Res. 69: 1640-1645.
40. 40. Sahl, H. G. 1994. Staphylococcin 1580 is identical to the lantibiotic epidermin: implications for the nature of bacteriocins from Gram-positive bacteria, Appl. Environ. Microbiol. 60: 752-755.
41. 41. Crupper, S. S., Gies, A. J., and Iandolo, J. J. 1997. Purification and characterization of Staphylococcin BacR1, a broad-spectrum bacteriocin, Appl. Environ. Microbiol. 63: 4185-4190.
42. 42. Podschun, R. and Ullmanna, U. 1996. Bacterioci ntyping of Klebsiella spp. isolated from different sources, Zentralbl. Hyg. Umwe. 198: 258-264.
43. 43. Bisaillon, J. G., Beaudet, R., Saheb, S. A., and Morisset, R. 1980. Interference of Neisseria gonorrhoeae growth by aerobic bacterial representatives of the urogenital flora, Rev. Can. Biol. 39: 201-208.
44. 44. Murray, P. R. and Rosenblatt, J. E. 1976. Bacterial interference by oropharyngeal and clinical isolates of anaerobic bacteria, J. Infect. Dis. 134: 281-285.
45. 45. Wilhelm, M. P., Lee, D. T., and Rosenblatt, J. E. 1987. Bacterial interference by anaerobic species isolated from human feces, Eur. J. Clin. Microbiol. 6: 266-270.
46. 46. Hinton, A., Jr. and Hume, M. E. 1997. Inhibition of Listeria monocytogenes growth by Veillonella cultured on a tartrate medium, Clin. Infect. Dis. 25(Suppl. 2): S120.
47. 47. Aly, R., Shinefield, R. H. and Maibach, H. 1982. Bacterial interference among Staphylococcus aureus strains, in Bacterial Interference, Aly, R. and Shinefield, H., Ed., CRC Press, Boca Raton, 13-23.
48. 48. Sprunt, K., Leidy, G., and Redman, W. 1980. Abnormal colonization of neonates in an intensive care unit: conversion to normal colonization by pharyngeal implantation of alphahemolytic streptococcus strain 215, Pediatr. Res. 14: 308-313.
49. 49. Brook, I. 1984. The role of β-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection, Rev. Infect. Dis. 6: 601-607.
50. 50. Sanders, W. E. 1969. Bacterial interference. I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci by Viridans streptococci, J. Infect. Dis. 120: 698-707.
51. 51. Crow, C. C., Sandera, W. E., Jr., and Longley, S. 1973. Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus, J. Infect. Dis. 128: 527-532.
52. 52. Sanders, C. C., Sanders, W. E., Jr., and Harrowe, D. J. 1976. Bacterial interference: effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci, Infect. Immun. 13: 808-812.
53. 53. Sanders, C. C., Nelson, G. E., and Sanders, W. E. 1977. Bacterial interference. IV. Epidemiologic determinants of the antagonistic activity of the normal throat flora against group A streptococci, Infect. Immun. 16: 599-603.
54. 54. Johanson, W. G., Blackstock, R., Pierce, A. K., and Sanford, J. P. 1970. The role of bacterial antagonism in pneumococcal colonization of the human pharynx, J. Lab. Clin. Med. 75: 946-952.
55. 55. Aly, R., Maibach, H. I., Shinefield, H. R., Mandel, A., and Strauss, W. G. 1974. Bacterial interference among strains of Staphylococcus aureus in man, J. Infect. Dis. 129: 720-724.
56. 56. Roos, K., Grahm, E., Lind, L., and Holm, S. 1989. Treatment of recurrent streptococcal tonsillitis by recolonization with alpha-streptococci, Eur. J. Clin. Microbiol. Infect. Dis. 8: 318-319.
57. 57. Dajani, A. S. and Wannamaker, L. W. 1971. Experimental infection of the skin in the hamster simulating human impetigo. III. Interaction between staphylococci and group A streptococci, J. Exp. Med. 134: 588-594.
58. 58. Dajani, A. S., Tom, M. C., and Law, D. J. 1976. Viridins, Enteriocins of alphahemolytic streptococci: Isolation, characterization, and partial purification, Antimicrob. Agents Chemother. 9: 81-88.
59. 59. Tagg, J. R., Dajani, A. S., Wannamaker, L. W., and Gray, E. D. 1973. Group A streptococcal bacteriocin. Production, purification, and mode of action, J. Exp. Med. 138: 1168-1183.
60. 60. Beck, A. 1979. Interference by an β-hemolytic streptococcus of -hemolytic pathogenic streptococci. Inflammation 3: 463-465.
61. 61. Grahn, E. and Holm, S.E. 1983. Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area, Zbl. Bakt. Hyg. A 256: 72-79.
62. 62. Roos, K., Grahn, E., and Holm, S. E. 1986. Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococal tonsillitis, Scand. J. Infect. Dis. 18: 313-319.
63. 63. Brook, I. and Gober, A. E. 1995. Role of bacterial interference and β-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis, Arch. Otolaryngol. Head Neck Surg. 121: 1405-1409.
64. 64. Brook, I. and Gober, A. E. 1999. Interference by aerobic and anaerobic bacteria in children with recurrent group A beta-hemolytic streptococcal tonsillitis. Arch. Otolaryngal. Head Neck Surg. 125: 225-554.
65. 65. Roos, K., Grahn, E., Holm, S. E., Johansson, H., and Lind, L. 1993. Interfering alpha-strep-tococci as a protection against recurrent streptococcal tonsillitis in children, Int. J. Pediatr. Ot. 25: 141-148.
66. 66. Roos, K., Holm, S. E., Grahn, E., and Lind, L. 1993. Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study, Scand. J. Infect. Dis. 25: 3135.
67. 67. Roos, K., Holm, S. E., Grahn-Hakansson, E., and Lagergren, L. 1996. Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis - a randomized placebo-controlled multicentre study, Scand. J. Infect. Dis. 28: 459-462.
68. 68. Grahn, E., Holm, S. E., and Roos, K. 1987. Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis, Scand. J. Infect. Dis. 19: 421-426.
69. 69. Brook, I. and Gillmore, J. D. 1993. Evaluation of bacterial interference and betalactamase production in the management of experimental infection with group A betahemolytic streptococci, Antimicrob. Agents. Chemother. 37: 1452-1455.
70. 70. Brook, I. and Foote, P. A. 1997. Effect of penicillin or cefprozil therapy on tonsillar flora, J. Antimicrob. Chemother. 40: 725-728.
71. 71. Mackowiak, P. A. 1983, The normal flora, N. Engl. J. Med. 307: 83-93.
72. 72. Sprunt, K. and Redman, W. 1968. Evidence suggesting importance of role of interbacterial inhibition in maintaining balance of normal flora, Ann. Intern. Med. 68: 579-590.
73. 73. Bernstein, J. M., Sagahtaheri-Altaie, S., Dryjd, D. M., and Wactawski-Wende, J. 1994. Bacterial interference in nasopharyngeal bacterial flora of otitis-prone and non-ototis-prone children, Acta. oto-rhino-laryngologica belgiun 48: 1-9.
74. 74. Faden, H., Zaz, M. J., Bernstein, J. M., Brodsky, L., Stamievich, J., and Ogru, P. L. 1991. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children, Ann. Otolo. Rhinolo. Laryngolo. 100: 612-615.
75. 75. Brook, I. and Gober, A. Bacterial interference in the nasopharynx of otitis media prone and not otitis media prone children, Arch. Otolaryngolo. Head Neck Surg. in press.
76. 76. Foote, P.A., Jr. and Brook, I. 1989. Penicillin and clindamycin therapy in recurrent tonsillitis. Effect of microbial flora, Arch. Otolaryngolo. Head Neck Surg. 15: 856-859.
77. 77. Brook, I. and Foote, P.A. 1997. Bacterial interference and beta-lactamase-producing bacteria in the adenoids after antimicrobial therapy, Rev. Inf. Dis. 25: 493.
78. 78. Brook, I. and Gober, A. E. 1998. Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media, J. Antimicrob. Chemother. 41: 489-492.
79. 79. Tannock, G. W. 1981. Microbial interference in the gastrointestinal tract, Asian J. Clinic Sci. 2: 2-34.
80. 80. Gorbach, S. L., Barza, M., Giuliano, M., and Jacobus, N. V. 1988. Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers, Eur. J. Clin. Microbiol. Infect. Dis. 7: 98-102.
81. 81. Kennedy, M. J. and Volz, P. A. 1985. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism, Infect. Immun. 49: 654-663.
82. 82. Wells, C. L., Maddaus, M. A., Jechorek, R. P., and Simmons, R. L. 1988. Role of intestinal anaerobic bacteria in colonization resistance, Eur. J. Clin. Microbiol. Infect. Dis. 7: 107-113.
83. 83. Goncharova, G. I., Semenova, L. P., Liannaia, A. M., Kozlova, E. P., and Donskikh, E. E. 1987. Human bifidobacterium flora, its normalizing and protective functions, Antibiot. Med. Biotekhnol. 32: 179-183.
84. 84. Mitsuoka, T., and Kaneuchi, C. 1977. Ecology of the bifidobacteria, Am. J. Clin. Nutr. 30: 1799-1810.
85. 85. Hentges, D. J. 1982. Inhibition of Shigella by the normal intestinal flora, in Bacterial Interference, Aly, R. and Shinefield, H. R., Ed., CRC Press, Boca Raton, 121-132.
86. 86. Hentges, D. J. and Freter, R. 1962. In vivo and in vitro antagonism of intestinal bacteria against Shigella flexneri. I. Correlation between various tests, J. Infect. Dis. 110: 30-37.
87. 87. Gilliland, S. E. and Speck, M. L. 1977. Antagonistic action of Lactobacilus acidophilus toward intestinal and food-borne pathogens in associative culture, J. Food Prot. 40: 820-823.
88. 88. Tannock, G. W. 1988. Mini review. Molecular genetics: a new tool for investigating the microbial ecology of the gastrointestinal tract?, Microb. Ecol 15: 239-256.
89. 89. Gilliland, S. E., Speck, M. L., Nauyok, G. F., and Giesbrecht, F. G. 1978. Influence of consuming nonfermented milk containing Lactobacillus acidophilus on fecal flora of healthy males, J. Dairy Sci. 61: 1-10.
90. 90. Pearce, J. L. and Hamilton J. B. 1974. Controlled trial of orally administered lactobacilli in acute infantile diarrhea, J. Pediatr. 84: 261-262.
91. 91. Pozo-Olano, J. de D., Warram, J. H., Gomez, R. G., and Cavazos, M. G. 1978. Effect of a lactobacilli preparation on traveler's diarrhea, Gastroenterology 74: 829-830.
92. 92. Beck C. and Nechelles, H. 1961. Beneficial effects of administration of Lactobacillus acidophilus in diarrheal and other intestinal disorders, Am. J. Gastroenterol. 35: 522-530.
93. 93. Settel, E. 1962. Lactobacillus acidophilus in the treatment of functional gastrointestinal disorders, Clin. Med. 69: 700-704.
94. 94. Chan, R. C. Y., Bruce, A. W., and Reid, G. 1984. Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of Gram-negative uropathogens by competitive exclusion, J. Urol. 131: 596-601.
95. 95. Reid, G., Bruce, A. W., and Cook, R. L. 1987. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract, J. Urol. 138: 330-335.
96. 96. McCormick, E. L. and Savage, D. C. 1983. Characterization of Lactobacillus sp. strain 10037 from the murine gastrointestinal tract: ecology, plasmid content, and antagnoistic activity toward Clostridium ramosom H1, Appl. Environ. Microbiol. 46: 1103-1112.
97. 97. Silva, M., Jacobus, N. V., Deneke, C., and Gorbach, S. L. 1987. Antimicrobial substance from a human Lactobacillus strain, Antimicrob. Agents Chemother. 31: 1231-1233.
98. 98. Gorbach, S. L., Chang, T. W., and Goldin, B. 1987. Successful treatment of relapsing Clostridium difficile colitis with Lactobacilus GG, Lancet ii: 1519.
99. 99. Itoh, K. and Freter, R. 1989. Control of Escherichia coli populations by a combination of indigenous clostridia and lactobacilli in gnotobiotic mice and continuous-flow cultures, Infect. Immun. 57: 559-565.
100. 100. Dong, M. Y., Chang, T. W., and Gorbach, S. L. 1987. Effects of feeding Lactobacillus GG on lethal irradiation in mice, Diagn. Microbiol. Infect. Dis. 7: 17.
101. 101. Korschunov, V. M., Smeyanov, V. V., Efimov, B. A., Tarabrina, N. P., Ivanov, A. A., and Baranov, A. E. 1996. Therapeutic use of an antibiotic-resistant Bifidobacterium preparation in men exposed to high-dose γ-irradiation, J. Med. Microbiol. 44: 70-74.
102. 102. Bruce, A. W., Reid, G., Chan, R. C. Y., and Costerton, J. W. 1984. Bacterial adherence in the human ileal conduit: a morphological and bacteriological study, J. Urol. 132: 184-188.
103. 103. Pfau, A. and Sacks, T. 1977. The bacterial flora of the vaginal vestibule, urethra and vagina in the normal pre-menopausal woman, J. Urol. 118: 292-295.
104. 104. Marrie, T. J., Harding, G. K. M., and Ronald, A. R. 1978. Anaerobic and aerobic urethral flora in healthy females, J. Clin. Microbiol. 8: 67-72.
105. 105. Reid, G., McGroarty, J. A., Angotti, R., and Cook, R. L. 1988. Lactobacillus inhibitor production against E. coli and co-aggregation ability with uropathogens, Can. J. Microbiol. 34: 344-351.
106. 106. McGroarty, J. A. and Reid, G. 1988. Detection of a lactobacillus substance which inhibits Escherichia coli, Can. J. Microbiol. 34: 974-978.
107. 107. Tramer, J. 1966. Inhibitory effect of Lactobacilus acidophilus. Nature, (London) 211: 204-205.
108. 108. Barefoot, S. F. and Klaenhammer, T. R. 1984. Purification and characterization of the Lactobacillus acidophilus bacteriocin lactaci B, Antimicrob. Agents Chemother. 26: 328-334.
109. 109. Joerger, M. C. and Klaenhammer, T. R. 1986. Characterization and purification of helveticin J and evidence for a chromosomally determined bacteriocin produced by Lactobacillus helveticus. 481, J. Bacteriol. 167: 439-446.
110. 110. Upreti, G. C. and Hinsdill, R. D. 1975. Production and mode of action of lactocin 27: bacteriocin from a homofermentative Lactobacilus, Antimicrob. Agents Chemother. 7: 139-145.
111. 111. Bruce, A. W. and Reid, G. 1988. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections, Can. J. Microbiol. 34: 339-343.
112. 112. Reid, G., McGroarty, J. A., Domingue, P. A. G., Chow, A. W., Bruce, A. W., Eisen, A., and Costerton, J. W. 1990. Co-aggregation of urogenital bacteria in vitro and in vivo, Curr. Microbiol. 20: 47-52.
113. 113. Friedlander, A., Druker, M. M., and Schachter, A. 1986. Lactobacillus acidophilus and vitamin B complex in the treatment of vaginal infection, Panminerva Med. 28: 51-53.
114. 114. Sandler B. 1979. Lactobacillus for vulvovaginitis, Lancet ii:791-792.
115. 115. Mardh, P. A. and Soltesz, L. V. 1983. In vitro interaction between lactobacilli and other microorganisms occurring in the vaginal flora, Scand. J. Infect. Dis. Suppl. 40: 47-51.
116. 116. Skarin, A. and Sylwan, J. 1986. Vaginal lactobacilli inhibiting growth of Gardnerella vaginalis, Mobiluncus and other bacterial species cultured from vaginal content of women with bacterial vaginosis, Acta. Pathol. Microbiol. Scand. Sect. B 94: 399-403.
117. 117. Sanders, C. C. and Sanders, W. E. 1982. Role of the endocervical flora in resistance to gonorrhea, in Bacterial Interference, Aly, R. and Shinefield, H. R., Ed., CRC Press, Boca Raton, 111-119.